Alnylam Pharmaceuticals
ALNY
#868
Rank
HK$230.07 B
Marketcap
HK$1,719
Share price
1.43%
Change (1 day)
-50.09%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company